This federal contract award to Edwards Lifesciences LLC, a for-profit limited liability company, is for the provision of Transcatheter Aortic Valve Replacement (TAVR) medical devices and related cardiovascular equipment to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The $34,000.00 firm fixed-price purchase order contract has a completion date of June 15, 2026 and was awarded on June 16, 2025. The contract is not associated with any set-aside designations.
Edwards Lifesciences LLC is a subsidiary of Edwards Lifesciences Corporation, a global leader in medical innovations for structural heart disease and critical care monitoring. The company has a significant Indefinite Delivery Contract (IDV) with the VA-VHA, specifically with Veterans Integrated Service Network 19, valued at $1,190,000 with a performance period through December 22, 2029. Additionally, the company maintains an active Blanket Purchase Agreement with the VA-VHA, valued at $1,590,000, which allows medical centers within Veterans Integrated Service Network 21 to order various Edwards heart valve models through 2028. These contract vehicles demonstrate Edwards Lifesciences' critical role in providing advanced cardiovascular medical technologies to the veteran healthcare system.
Generated 7/1/25, 10:34 AM